As of 2025-06-30, the Relative Valuation of Black Diamond Therapeutics Inc (BDTX) is 2.37 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.48 USD, the upside of Black Diamond Therapeutics Inc based on Relative Valuation is -4.3%.
The range of the Relative Valuation is 1.81 - 2.58 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.2x - 26.3x | 25.3x |
| Forward P/E multiples | 21.9x - 28.9x | 27.7x |
| Fair Price | 1.81 - 2.58 | 2.37 |
| Upside | -27.0% - 4.2% | -4.3% |
| Date | P/E |
| 2025-06-26 | 27.48 |
| 2025-06-25 | 28.93 |
| 2025-06-24 | 27.81 |
| 2025-06-23 | 25.35 |
| 2025-06-20 | 26.02 |
| 2025-06-18 | 26.02 |
| 2025-06-17 | 25.91 |
| 2025-06-16 | 26.69 |
| 2025-06-13 | 25.80 |
| 2025-06-12 | 27.14 |
| 2025-06-11 | 26.47 |
| 2025-06-10 | 27.48 |
| 2025-06-09 | 27.70 |
| 2025-06-06 | 28.82 |
| 2025-06-05 | 27.81 |
| 2025-06-04 | 28.37 |
| 2025-06-03 | 27.92 |
| 2025-06-02 | 26.47 |
| 2025-05-30 | 24.57 |
| 2025-05-29 | 25.13 |
| 2025-05-28 | 22.23 |
| 2025-05-27 | 22.90 |
| 2025-05-23 | 22.45 |
| 2025-05-22 | 23.01 |
| 2025-05-21 | 22.67 |
| 2025-05-20 | 24.24 |
| 2025-05-19 | 23.57 |
| 2025-05-16 | 21.78 |
| 2025-05-15 | 21.56 |
| 2025-05-14 | 21.11 |
| 2025-05-13 | 21.56 |
| 2025-05-12 | 19.55 |
| 2025-05-09 | 18.32 |
| 2025-05-08 | 18.88 |
| 2025-05-07 | 17.31 |
| 2025-05-06 | 16.36 |
| 2025-05-05 | 18.65 |
| 2025-05-02 | 19.88 |
| 2025-05-01 | 18.99 |
| 2025-04-30 | 18.99 |
| 2025-04-29 | 17.87 |
| 2025-04-28 | 17.87 |
| 2025-04-25 | 17.76 |
| 2025-04-24 | 17.98 |
| 2025-04-23 | 17.65 |
| 2025-04-22 | 17.42 |
| 2025-04-21 | 16.64 |
| 2025-04-17 | 16.08 |
| 2025-04-16 | 15.19 |
| 2025-04-15 | 15.86 |